Special Forms of Cystitis

Slide 1 · SPECIAL FORMS OF CYSTITIS

Interstitial cystitis (bladder pain syndrome) and malakoplakia

Clinicopathologic mechanisms • morphology • diagnostic reasoning

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Define bladder pain syndrome using the source-described clinical framework.

Recognize cystoscopic and tissue findings in interstitial cystitis.

Explain malakoplakia through bacterial persistence and defective phagocyte processing.

Identify von Hansemann histiocytes and Michaelis–Gutmann bodies.

Apply key diagnostic exclusions and morphologic discriminators.

Slide 3 · Two distinctive inflammatory entities

Interstitial cystitis

Clinical pain syndrome

Cause remains unknown

Often nonspecific histology

Biopsy chiefly excludes CIS

Malakoplakia

Distinctive chronic tissue reaction

Chronic bacterial setting

Defective phagocyte processing

Characteristic histiocytic inclusions

Slide 4 · Why these are “special” forms

Cystitis

A spectrum of bladder inflammation

Pain-dominant syndrome

Interstitial cystitis

Morphology-dominant reaction

Malakoplakia

The two subtypes are distinguished by different clinical and pathologic signatures.

Slide 5 · The pathology question differs by entity

In suspected bladder pain syndrome

Describe any tissue changes cautiously.

Recognize histology as nonspecific.

Exclude carcinoma in situ (CIS).

In suspected malakoplakia

Identify macrophage-rich inflammation.

Seek distinctive cytoplasmic inclusions.

Correlate with chronic bacterial context.

Slide 6 · Bladder pain syndrome: Core definition

Bladder-related pain, pressure, or discomfort with associated urinary symptoms.

Symptoms persist for more than six weeks.

Infection and other identifiable causes must be absent.

This is a clinical syndrome—not a specific histologic pattern.

Slide 7 · The duration criterion matters

Symptom onset

A bladder-related unpleasant sensation

Persistent symptoms

Urinary symptoms continue

> 6 weeks

Textbook-quoted AUA threshold

The threshold is part of the cited definition; Duration alone does not establish the diagnosis.

Slide 8 · Exclusion is embedded in the definition

Bladder-related symptoms

Pain / pressure / discomfort

Assess other causes

Infection or another identifiable explanation?

If no cause is identified

Bladder pain syndrome may be considered

This diagram paraphrases the historical definition quoted; It is not a complete clinical guideline.

Slide 9 · Epidemiologic context and uncertainty

Observed distribution

Occurs most frequently in females.

The textbook does not give a prevalence estimate in this section.

Etiologic interpretation

Cause is described as unknown.

Morphologic findings do not establish a unique mechanism.

Slide 10 · Interstitial cystitis: Presenting pattern

Suprapubic pain

Frequency

Urgency

Dysuria

Hematuria

Bladder pain syndrome

Symptoms can coexist; The mixture alone is not pathognomonic.

Slide 11 · The pain phenotype

Pain description

Intermittent and sometimes severe.

Usually localized to the suprapubic region.

How to interpret it

Perceived as bladder-related.

Must be assessed alongside lower urinary tract symptoms and exclusions.

Slide 12 · Storage symptoms form part of the syndrome

Frequency

Repeated need to void.

Part of the syndrome’s urinary symptom cluster.

Urgency

Prominent symptom description.

Not specific to this disorder in isolation.

Slide 13 · Dysuria and hematuria require caution

Source-described symptoms

Dysuria can accompany the pain syndrome.

Hematuria is also described.

Diagnostic implication

Neither symptom independently identifies interstitial cystitis.

Alternative causes remain important when evaluating the syndrome.

Slide 14 · Clinical syndrome, not a single symptom

Bladder-related discomfort

Pain / pressure

Other urinary features

Frequency, urgency or dysuria

Negative explanatory work-up

No infection or other established cause

The combination supports a syndromic assessment; Individual symptoms are nonspecific.

Slide 15 · Cystoscopic appearances may be abnormal

Schematic — not a clinical or histologic specimen

Mucosal fissures are described.

Punctate mucosal hemorrhages are called glomerulations.

The cystoscopic findings are not equivalent to a definitive histologic test.

Slide 16 · Glomerulations: Punctate hemorrhages

Schematic — not a clinical or histologic specimen

Small, punctate mucosal hemorrhages.

Described as a typical cystoscopic finding.

Interpret within the wider symptom and exclusion context.

Slide 17 · Mucosal fissures: Another visual pattern

Schematic — not a clinical or histologic specimen

Linear breaks in the mucosal surface may be seen.

Fissures and glomerulations are visually distinct lesions.

Cystoscopy depicts the mucosal surface; Biopsy samples tissue.

Slide 18 · Histology is frequently nonspecific

There is no defining microscopic pattern in most cases.

The source explicitly characterizes the microscopic pathology as nonspecific.

A nonspecific biopsy cannot, by itself, prove the pain syndrome.

Histology must be interpreted in clinical context.

Slide 19 · Mast cells may be increased

Schematic — not a clinical or histologic specimen

Mast cells are often increased in the submucosa.

The observation is described in the Robbins section.

It is not presented as a stand-alone diagnostic criterion.

Slide 20 · A finding is not automatically a mechanism

Observation

Often more submucosal mast cells

Uncertain pathogenic significance

The text explicitly leaves the contribution of mast cells unresolved.

Slide 21 · The main role of biopsy: Exclusion

Clinically suspected interstitial cystitis

Pain and urinary symptoms

Bladder biopsy

Tissue examination

Priority: Rule out CIS

Exclude a clinically mimicking malignancy

This summarizes the stated primary purpose of biopsy, not a universal biopsy indication.

Slide 22 · Carcinoma in situ is an important mimic

Bladder pain syndrome

Characteristic clinical complaint: Bladder-related pain plus urinary symptoms.

Histology may be nonspecific.

Urothelial CIS

Can present with a clinically similar symptom pattern.

Requires exclusion when relevant by evaluating tissue morphology.

Slide 23 · Avoid the diagnostic shortcut

Symptoms suggest interstitial cystitis

Clinical assessment

Look for a clinically explanatory cause, including infection

Pathology assessment

When tissue is sampled, exclude carcinoma in situ

A syndromic label must not replace appropriate exclusion of mimics.

Slide 24 · Hunner ulcers identify a subset

Schematic — not a clinical or histologic specimen

Some affected individuals develop chronic mucosal ulcers.

These are termed Hunner ulcers in the source.

Their presence distinguishes an ulcerative phenotype; Not all cases have them.

Slide 25 · Classic ulcerative disease

Textbook terminology

Hunner-associated cases are described as late, classic or ulcerative phase.

Interpretation limit

The text says “some cases”; Do not imply that ulceration is inevitable.

Avoid assuming that every patient follows one sequence.

Slide 26 · Late wall injury may extend deeply

Mucosa: Chronic ulcer

Wall: Progressive transmural fibrosis

Functional end result: Contraction

Schematic spatial pathway; “may” denotes a possible consequence, not inevitable progression.

Slide 27 · A contracted bladder is a late consequence

Persistent severe disease

Some cases have chronic ulceration

Transmural fibrosis

Fibrous remodeling across the wall

Contracted bladder

Reduced distensibility by inference

Only the sequence to contracted bladder is stated directly; Reduced distensibility is explanatory inference.

Slide 28 · Separate typical findings from late outcomes

Finding

Role in source

Interpretation

Glomerulations

Cystoscopic observation

Punctate hemorrhages

Hunner ulcers

Subset of patients

Classic ulcerative phenotype

Transmural fibrosis

Possible late change

May produce contracted bladder

Slide 29 · Why treatment remains empiric

The source describes treatment as largely empiric.

Underlying cause is not established.

Histologic abnormalities are frequently nonspecific.

No universal treatment algorithm is provided in this Robbins section.

Slide 30 · Interstitial cystitis: Evidence boundaries

Grounded observations

Bladder-related symptoms > six weeks.

Typical cystoscopic patterns and possible ulcers.

Mast-cell increase sometimes noted.

What not to overclaim

A proven single etiology.

Mast cells as diagnostic proof.

Inevitable ulceration or contraction.

Slide 31 · Case exercise: Painful bladder symptoms

Illustrative teaching vignette

An adult woman has prolonged bladder-related suprapubic discomfort, frequency and urgency. Investigation has not identified infection or another cause.

Clinical / pathologic question

Which diagnosis is suggested, and what important mimic must be considered if bladder tissue is examined?

Slide 32 · Case reasoning: A syndrome plus an exclusion

Syndromic fit

Bladder-related discomfort with urinary symptoms lasting beyond the defined window.

Main uncertainty

A clinical pattern is not an etiologic or histologic proof.

Pathology priority

The biopsy role emphasized by Robbins is to rule out CIS.

Slide 33 · Malakoplakia: A distinctive inflammatory reaction

A chronic macrophage-rich reaction associated with defective intracellular handling of bacterial material.

Distinctive morphology contrasts with the nonspecific histology of interstitial cystitis.

The pathogenic defect is believed to be acquired.

Clinical context often includes persistent bacterial infection.

Slide 34 · A chronic bacterial setting

Chronic infection

Persistence of bacterial material

Impaired phagocyte function

Acquired processing defect

Malakoplakia

Macrophage-rich inflammatory lesions

Proposed explanatory pathway from the textbook; Not a demonstrated invariant sequence.

Slide 35 · Organisms named in the source

Most frequent association

Escherichia coli.

Chronic bacterial infection is central to the described setting.

Occasional association

Proteus species.

The list is not an exhaustive microbiologic classification.

Slide 36 · Immunosuppression increases association

Clinical context

The condition occurs more frequently in immunosuppressed patients.

Renal transplant recipients as an example.

Pathogenetic relation

Impaired host handling of bacteria is consistent with the proposed lesion mechanism.

Association does not prove the defect in every individual case.

Slide 37 · Renal transplantation: A source example

Illustrative teaching vignette

A renal transplant recipient with a chronic bacterial urinary tract setting develops unusual bladder mucosal plaques.

Clinical / pathologic question

Which chronic inflammatory lesion should be included in the morphologic consideration?

Slide 38 · Acquired defects in phagocyte function

Bacterial challenge

Defective intracellular degradation

Persistent phagocytosed material

The causal explanation is described as apparent/proposed in the source, not as fully established for every case.

Slide 39 · The phagolysosomal step matters

Uptake

Bacterial material enters phagocyte

Processing

Phagolysosome function is defective

Persistence

Particulate and membranous debris remains

Proposed mechanism shown as an educational sequence; Not a quantitative model.

Slide 40 · Debris accumulation explains the cytoplasm

Schematic — not a clinical or histologic specimen

Macrophages contain numerous phagosomes.

Phagosomes retain particulate and membranous bacterial debris.

The result is abundant granular cytoplasm.

Slide 41 · Gross malakoplakia: Yellow mucosal plaques

Schematic — not a clinical or histologic specimen

Soft, slightly elevated mucosal plaques.

Typically described as yellow or yellow-orange.

A distinctive cystoscopic appearance.

Slide 42 · Plaque size and texture are descriptive

3–4 cm

Typical plaque diameter reported in the source

Soft surface, slightly raised contour.

Color and plaque pattern support consideration of malakoplakia.

Macroscopic appearance should be matched to the microscopic lesion.

Slide 43 · Histology: Aggregates of large macrophages

Schematic — not a clinical or histologic specimen

Macrophages form conspicuous aggregates.

Abundant granular or foamy cytoplasm creates the characteristic cellular background.

The lesion is a distinctive chronic inflammatory reaction.

Slide 44 · Von Hansemann histiocytes

Schematic — not a clinical or histologic specimen

Name for the large characteristic lesional macrophages.

Cells are rich in coarse granular cytoplasm.

Recognition guides the search for Michaelis–Gutmann bodies.

Slide 45 · Accompanying inflammatory cells

Schematic — not a clinical or histologic specimen

Occasional multinucleated giant cells may be present.

Lymphocytes may accompany macrophage aggregates.

The macrophage predominance is the defining cellular pattern.

Slide 46 · PAS-positive granular cytoplasm

Schematic — not a clinical or histologic specimen

The source figure depicts granular PAS-positive macrophage cytoplasm.

This aligns with accumulation of phagocytosed material.

PAS positivity is descriptive; The defining inclusions are evaluated separately.

Slide 47 · Michaelis–Gutmann bodies

Schematic — not a clinical or histologic specimen

Characteristic rounded mineralized concretions.

Typically present within the macrophages.

May appear laminated or target-like in a schematic depiction.

Slide 48 · How Michaelis–Gutmann bodies form

Defective digestion

Enlarged lysosomal compartments

Residual contents

Material persists intracellularly

Mineralization

Calcium deposits form laminated concretions

Proposed mechanism shown as an educational sequence; Not a quantitative model.

Slide 49 · Microscopic recognition sequence

Macrophage-rich chronic inflammation

Large von Hansemann histiocytes

Granular cytoplasm

Stored particulate / membranous debris

Michaelis–Gutmann bodies

Characteristic mineralized inclusions

Morphologic sequence for recognition, not a formal diagnostic scoring system.

Slide 50 · Gross and microscopic features must align

Cystoscopic lesion

Soft, yellow-orange raised plaques.

Typical size stated as approximately 3–4 cm.

Microscopic lesion

Large macrophage aggregates with granular cytoplasm.

Michaelis–Gutmann mineralized inclusions.

Slide 51 · Malakoplakia is not limited to the bladder

Kidneys, prostate and epididymis

Colon and other GI tract

Brain and lungs

Bone

Endometrium

Malakoplakia

Examples of other locations explicitly named.

Slide 52 · Case exercise: Yellow plaques and inclusions

Illustrative teaching vignette

Cystoscopy shows soft yellow bladder plaques. Tissue sampling reveals aggregates of large macrophages with granular cytoplasm and intracytoplasmic laminated concretions.

Clinical / pathologic question

Name the condition, its characteristic cells, and the inclusions.

Slide 53 · Case reasoning: Link cell injury to morphology

Clinical setting

Chronic bacterial context, especially E. Coli; Possible immunosuppression.

Cellular lesion

Macrophages have defective intracellular bacterial processing.

Diagnostic pattern

Granular histiocytes and mineralized Michaelis–Gutmann bodies.

Slide 54 · Interstitial cystitis versus malakoplakia

Feature

Interstitial cystitis

Malakoplakia

Core phenotype

Bladder-related pain syndrome

Distinctive chronic inflammatory reaction

Cause / association

Unknown etiology

Chronic bacteria; impaired phagocytes

Tissue pattern

Usually nonspecific

Histiocytes and mineralized inclusions

Critical clue

Exclude CIS on biopsy

Michaelis–Gutmann bodies

Slide 55 · A practical pattern-recognition pathway

What dominates the clinical/pathologic picture?

Clinical assessment

Pain syndrome + negative explanatory work-up → consider bladder pain syndrome

Pathology assessment

Yellow plaques + histiocytes + inclusions → consider malakoplakia

Always integrate symptoms, morphology and clinical context; This is a teaching schematic.

Slide 56 · Three common interpretation pitfalls

Pitfall

Why it is incorrect

Safer inference

Mast cells prove IC

Pathogenic meaning uncertain

Descriptive observation only

All IC has Hunner ulcers

Source says some cases

Specify ulcerative subset

Macrophages alone prove malakoplakia

Macrophages are nonspecific

Seek Michaelis–Gutmann bodies

Slide 57 · Applied discrimination: Three statements

Identify the only statement supported by Robbins.

A. In suspected bladder pain syndrome, biopsy chiefly establishes a unique inflammatory pattern.

B. Von Hansemann histiocytes accumulate partly degraded bacterial material.

C. Hunner ulcers occur in all bladder pain syndrome cases.

Slide 58 · Applied discrimination: Interpretation

Statement A — unsupported

Microscopic abnormalities in IC are generally nonspecific; Biopsy chiefly excludes CIS.

Statement B — supported

Defective phagolysosome processing leaves bacterial debris in the histiocyte cytoplasm.

Statement C — unsupported

Only some IC cases develop Hunner ulcers.

Slide 59 · Synthesis: Two different diagnostic logics

Interstitial cystitis

Syndrome first, exclusions essential.

Histology often nonspecific.

CIS is the critical tissue mimic.

Malakoplakia

Tissue pattern is strongly informative.

Look for granular macrophages.

Seek characteristic mineralized inclusions.

Slide 60 · Primary reference and visual provenance

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th ed. (2026). Chapter 21, pp. 869–870.

Topic scope: “Special Forms of Cystitis”; contextual distinction from adjacent “Acute and Chronic Cystitis”.

All anatomical and microscopic diagrams in this deck are original, native PowerPoint schematics—not actual clinical or histologic specimens.